NCT04785976 Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage
| NCT ID | NCT04785976 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tiantan Hospital |
| Condition | Aneurysmal Subarachnoid Hemorrhage |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2012-04-01 |
| Primary Completion | 2032-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2012-04-01 with a primary completion date of 2032-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rupture of intracranial aneurysms can lead to extensive subarachnoid hemorrhage (SAH), a potentially fatal neurological emergency with mortality rates ranging from 8 to 67%. At present, surgical clipping (SC) and endovascular coiling (EC) are two main treatments for aneurysmal subarachnoid hemorrhage (aSAH), in recent years, the improvements in surgical equipment and techniques have already greatly improved the postoperative safety of patients. However, considering individual differences between patients, some still at risk due to possible complications during hospitalization or after discharge from the hospital, it will no doubt generate a large healthcare burden. This prospective, observational clinical trial (LongTEAM) is to improve the diagnosis and treatment effect and efficiency in this field, reducing mortality, medical costs, and medical burden, while opening up new avenues for interdisciplinary clinical practice and scientific research exploration.
Eligibility Criteria
Inclusion Criteria: * All patients admitted to the emergency department of the investigator with aneurysmal subarachnoid hemorrhage are included in their prospective registry. Exclusion Criteria: * None
Contact & Investigator
Fa Lin, MD
PRINCIPAL INVESTIGATOR
Beijing Tiantan Hospital
Frequently Asked Questions
Who can join the NCT04785976 clinical trial?
This trial is open to participants of all sexes, studying Aneurysmal Subarachnoid Hemorrhage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04785976 currently recruiting?
Yes, NCT04785976 is actively recruiting participants. Contact the research team at 1011168227@qq.com for enrollment information.
Where is the NCT04785976 trial being conducted?
This trial is being conducted at Beijing, China, Neijiang, China.
Who is sponsoring the NCT04785976 clinical trial?
NCT04785976 is sponsored by Beijing Tiantan Hospital. The principal investigator is Fa Lin, MD at Beijing Tiantan Hospital. The trial plans to enroll 5,000 participants.